Novo Nordisk, the Danish pharmaceutical giant, surged to a new high in trading, marking an 8% increase in its shares. This ascent continues a trend seen over several months, driven by skyrocketing optimism surrounding weight-loss medications.Novo Nordisk's experimental weight-loss pill, ...